CU24238B1 - Vacuna de proteína quimérica contra la neumonía causada por streptococcus pneumoniae - Google Patents
Vacuna de proteína quimérica contra la neumonía causada por streptococcus pneumoniaeInfo
- Publication number
- CU24238B1 CU24238B1 CUP2014000145A CU20140145A CU24238B1 CU 24238 B1 CU24238 B1 CU 24238B1 CU P2014000145 A CUP2014000145 A CU P2014000145A CU 20140145 A CU20140145 A CU 20140145A CU 24238 B1 CU24238 B1 CU 24238B1
- Authority
- CU
- Cuba
- Prior art keywords
- streptococcus pneumoniae
- chemeric
- pneumoniae
- vaccine against
- protein vaccine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
Abstract
El problema a resolver: ausencia de una vacuna eficiente segura para la profilaxis y el tratamiento de enfermedades causadas por Streptococcus pneumoniae (S.pneumoniae) capaz de proporcionar defensa contra todas las cepas de S.pneumoniae (ausencia de una vacuna universal contra neumococos). La solución: Una vacuna basada en una proteína quimérica que consiste en epítopos inmunogénicos de proteínas conservadoras de Streptococcus pneumoniae: PspA, Spr1895, y PsaA, así como también los componentes de la flagellina, conectadas a través de uniones flexibles. Se muestran seguridad, eficacia y ambos efectos preventivos y terapéuticos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2012126328/15A RU2510281C2 (ru) | 2012-06-22 | 2012-06-22 | ВАКЦИНА ПРОТИВ ПНЕВМОНИИ, ВЫЗЫВАЕМОЙ Streptococcus pneumoniae, НА ОСНОВЕ ГИБРИДНОГО БЕЛКА |
PCT/RU2013/000525 WO2013191591A1 (en) | 2012-06-22 | 2013-06-21 | Chimeric protein vaccine against pneumonia caused by streptococcus pneumoniae |
Publications (2)
Publication Number | Publication Date |
---|---|
CU20140145A7 CU20140145A7 (es) | 2015-04-29 |
CU24238B1 true CU24238B1 (es) | 2017-02-02 |
Family
ID=49769080
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CUP2014000145A CU24238B1 (es) | 2012-06-22 | 2013-06-21 | Vacuna de proteína quimérica contra la neumonía causada por streptococcus pneumoniae |
Country Status (13)
Country | Link |
---|---|
US (1) | US9345757B2 (es) |
EP (1) | EP2863944B1 (es) |
JP (1) | JP6195089B2 (es) |
KR (1) | KR20150034192A (es) |
CN (1) | CN104470538B (es) |
BR (1) | BR112014032135A2 (es) |
CU (1) | CU24238B1 (es) |
EA (1) | EA027981B1 (es) |
HK (1) | HK1208632A1 (es) |
MX (1) | MX355642B (es) |
RU (1) | RU2510281C2 (es) |
UA (1) | UA116634C2 (es) |
WO (1) | WO2013191591A1 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104844712B (zh) * | 2015-04-03 | 2019-06-28 | 长春百克生物科技股份公司 | 肺炎链球菌蛋白抗原及其制备方法和应用 |
RU2591809C1 (ru) * | 2015-07-21 | 2016-07-20 | Андрей Дмитриевич Протасов | Способ активации факторов противовирусной защиты у пациентов с хронической обструктивной болезнью легких |
RU2627602C2 (ru) * | 2015-12-29 | 2017-08-09 | Федеральное бюджетное учреждение науки Государственный научный центр прикладной микробиологии и биотехнологии (ФБУН ГНЦ ПМБ) | Способ получения химерного рекомбинантного белка fliC:pagN |
CA3044112A1 (en) | 2016-12-03 | 2018-06-07 | The Uab Research Foundation | Pneumococcal vaccine combining selected alpha helical domains and proline rich domains of pneumococcal surface protein a |
EP3661546B1 (en) * | 2017-08-03 | 2023-12-13 | Intervet International B.V. | A vaccine for protection against streptococcus suis |
RU2687488C1 (ru) * | 2018-07-12 | 2019-05-14 | Федеральное государственное бюджетное научное учреждение "Всероссийский научно-исследовательский и технологический институт биологической промышленности" ФГБНУ ВНИТИБП | Формолвакцина полиштаммная против пневмоний телят стрептококковой этиологии |
RU2720614C9 (ru) * | 2020-04-23 | 2021-02-09 | федеральное государственное бюджетное учреждение «Национальный исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи» Министерства здравоохранения Российской Федерации | Иммунобиологическое средство и способ его использования для индукции специфического иммунитета против вируса тяжелого острого респираторного синдрома SARS-CoV-2 (варианты) |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6936252B2 (en) | 1998-07-27 | 2005-08-30 | Microbial Technics Limited | Streptococcus pneumoniae proteins and nucleic acid molecules |
CA2379327A1 (en) * | 1999-06-10 | 2000-12-21 | Uab Research Foundation | Pneumococcal surface protein combination vaccine |
GB0022742D0 (en) * | 2000-09-15 | 2000-11-01 | Smithkline Beecham Biolog | Vaccine |
WO2002083855A2 (en) | 2001-04-16 | 2002-10-24 | Wyeth Holdings Corporation | Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
EP2314719A1 (en) | 2003-04-15 | 2011-04-27 | Intercell AG | S. pneumoniae antigens |
EP1477802A1 (en) | 2003-05-16 | 2004-11-17 | Erasmus Universiteit Rotterdam | Method for selecting and producing vaccine components and vaccines based thereon |
EP2371843B1 (en) | 2005-05-19 | 2014-09-17 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services | Functional epitopes of streptococcus pneumoniae psaA antigen and uses thereof |
AR058707A1 (es) * | 2005-12-22 | 2008-02-20 | Glaxosmithkline Biolog Sa | Vacuna, procedimiento para fabricarla y su uso |
SI2300609T1 (sl) * | 2008-06-25 | 2014-04-30 | Inserm Institut National De La Sante Et De La Recherche Medicale | Nove imunoadjuvantne spojine na osnovi flagelina in njihova uporaba |
WO2010045620A1 (en) * | 2008-10-17 | 2010-04-22 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | Recombinant bacterium capable of eliciting an immune response against streptococcus pneumoniae |
US8003112B2 (en) | 2009-04-16 | 2011-08-23 | Howard University | Meningococcal and pneumococcal conjugate vaccine and method of using same |
US20120135037A1 (en) * | 2009-06-01 | 2012-05-31 | Mizel Steven B | Flagellin fusion proteins and conjugates comprising pneumococcus antigens and methods of using the same |
-
2012
- 2012-06-22 RU RU2012126328/15A patent/RU2510281C2/ru not_active IP Right Cessation
-
2013
- 2013-06-21 KR KR20157001672A patent/KR20150034192A/ko active IP Right Grant
- 2013-06-21 EA EA201590078A patent/EA027981B1/ru not_active IP Right Cessation
- 2013-06-21 UA UAA201500499A patent/UA116634C2/uk unknown
- 2013-06-21 CN CN201380037745.9A patent/CN104470538B/zh not_active Expired - Fee Related
- 2013-06-21 BR BR112014032135A patent/BR112014032135A2/pt not_active IP Right Cessation
- 2013-06-21 WO PCT/RU2013/000525 patent/WO2013191591A1/en active Application Filing
- 2013-06-21 EP EP13806364.9A patent/EP2863944B1/en active Active
- 2013-06-21 CU CUP2014000145A patent/CU24238B1/es unknown
- 2013-06-21 JP JP2015518363A patent/JP6195089B2/ja not_active Expired - Fee Related
- 2013-06-21 MX MX2014016049A patent/MX355642B/es active IP Right Grant
-
2014
- 2014-12-22 US US14/579,279 patent/US9345757B2/en active Active
-
2015
- 2015-09-25 HK HK15109455.2A patent/HK1208632A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2013191591A9 (en) | 2014-02-13 |
JP2015521618A (ja) | 2015-07-30 |
JP6195089B2 (ja) | 2017-09-20 |
MX355642B (es) | 2018-04-25 |
HK1208632A1 (en) | 2016-03-11 |
EP2863944A4 (en) | 2016-05-11 |
US20150174230A1 (en) | 2015-06-25 |
BR112014032135A2 (pt) | 2017-08-01 |
RU2012126328A (ru) | 2013-12-27 |
EP2863944A1 (en) | 2015-04-29 |
WO2013191591A1 (en) | 2013-12-27 |
EP2863944B1 (en) | 2018-12-19 |
EA027981B1 (ru) | 2017-09-29 |
WO2013191591A4 (en) | 2014-04-03 |
CN104470538B (zh) | 2017-12-22 |
KR20150034192A (ko) | 2015-04-02 |
MX2014016049A (es) | 2015-07-06 |
US9345757B2 (en) | 2016-05-24 |
CU20140145A7 (es) | 2015-04-29 |
EA201590078A1 (ru) | 2015-06-30 |
CN104470538A (zh) | 2015-03-25 |
RU2510281C2 (ru) | 2014-03-27 |
UA116634C2 (uk) | 2018-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CU24238B1 (es) | Vacuna de proteína quimérica contra la neumonía causada por streptococcus pneumoniae | |
MX2017001406A (es) | Agentes a base de flagelina y usos de los mismos, incluyendo vacunación efectiva. | |
AR098256A1 (es) | Vectores para expresión de antígenos asociados a próstata | |
MX2017009308A (es) | Composiciones inmunogenicas para usar en vacunas neumococicas. | |
CR20130377A (es) | Métodos y productos de fármaco para tratar enfermedad de alzheimer | |
BR112013020517A2 (pt) | dispositivo de segurança | |
BR112017005833A8 (pt) | Vacinas recombinantes fmdv e seus usos | |
BR112016012862A2 (pt) | formulações para vacinas para neoplasia | |
BR112015012332A2 (pt) | dispositivo de scanner dental | |
MX2015008627A (es) | Derivados de acido boronico y usos terapeuticos de los mismos. | |
BR112012023046A2 (pt) | vacinas de vírus de febre aftosa recombinantes e seus respectivos usos | |
PE20150764A1 (es) | Niclosamida para el tratamiento de tumores solidos | |
CL2017000625A1 (es) | Composiciones de glicoconjugado inmunogénico/terapéutico y sus usos | |
CL2015001562A1 (es) | Método para obtener una vacuna de mycoplasma. | |
WO2013185764A3 (en) | Pharmaceutical compositions for combination therapy | |
IN2015MN00038A (es) | ||
MX2017013564A (es) | Formulaciones de glucopiranosil lipido a y alérgenos de cacahuete para administración sublingual. | |
BR112016007390A2 (pt) | vacina de haemophilus parasuis sorotipo tipo quatro | |
MX2016001695A (es) | Composiciones inmunogenas de combinacion. | |
DOP2014000140A (es) | Preparaciones que comprenden emodépsido amorfo | |
CO6761349A2 (es) | Proteína antimicrobiana | |
GB2515222A (en) | Use of flagellin as a vaccine | |
AR090726A1 (es) | Vacunas y procedimientos para tratar la enfermedad de lyme en perros | |
NI201500109A (es) | Vacuna polivalente de proteína de fusión contra la influenza | |
CU20130041A7 (es) | Micobacteria recombinante como vacuna contra la tuberculosis para uso en humanos |